Mark A. Goldsmith, See Remarks at Revolution Medicines, Inc. (RVMD), sold 13,199 shares at $39.99 ($528K) on 2024-06-03, disclosed to the SEC on 2024-06-05.
Scheduled sale ($528k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.09 | 900 | $35K | 6.7% |
| 2 | $39.99 | 5,699 | $228K | 43.2% |
| 3 | $39.99 | 5,699 | $228K | 43.2% |
| 4 | $40.93 | 901 | $37K | 7.0% |
| Total | $39.99 avg | 13,199 | $528K | 100% |
| Filing → |
| RVMD | SELL | 2026-06-18 | $1.6M | — | Filing → |
| RVMD | SELL | 2026-04-17 | $18.0M | — | Filing → |
| RVMD | SELL | 2026-03-19 | $2.6M | — | Filing → |